Skip to main content

Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing.

Publication ,  Journal Article
Haga, SB; Mills, R; Moaddeb, J; Liu, Y; Voora, D
Published in: Pharmgenomics Pers Med
2021

OBJECTIVE: This study assessed pharmacist experiences with delivering pharmacogenetic (PGx) testing in independent community pharmacies. METHODS: We conducted a cluster randomized trial of independent community pharmacies in North Carolina randomized to provide either PGx testing as a standalone service or integrated into medication therapy management (MTM) services. Surveys and pharmacist data about the delivery of PGx testing were collected. Semi-structured interviews were also conducted. RESULTS: A total of 36 pharmacists participated in the study from 22 pharmacies. Sixteen pharmacists completed the pre-study and post-study surveys, and four pharmacists completed the semi-structured interviews. Thirty-one percent (11/36) of pharmacists had had some education in personalized medicine or PGx prior to the study. The only outcome that differed by study arm was the use of educational resources, with significantly higher utilization in the PGx testing only arm (p=0.007). Overall, compared to the pre-study assessment, pharmacists' knowledge about PGx significantly improved post-study (p=0.018). In the post-study survey, almost all pharmacists indicated that they felt qualified/able to provide PGx testing at their pharmacy. While 75% of pharmacists indicated that they may continue to provide PGx testing at their pharmacy after the study, the major concerns were lack of reimbursement for PGx counseling and consultation given the necessary time required. CONCLUSION: Our findings demonstrated a positive experience with delivering PGx testing in the community pharmacy setting with little difference in pharmacists' experiences in providing PGx testing with or without MTM. Pharmacists were confident in their ability to provide PGx testing and were interested in continuing to offer testing, though sustained delivery may be challenged by lack of prescribing provider engagement and reimbursement.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pharmgenomics Pers Med

DOI

ISSN

1178-7066

Publication Date

2021

Volume

14

Start / End Page

877 / 886

Location

New Zealand

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Haga, S. B., Mills, R., Moaddeb, J., Liu, Y., & Voora, D. (2021). Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing. Pharmgenomics Pers Med, 14, 877–886. https://doi.org/10.2147/PGPM.S314972
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Yiling Liu, and Deepak Voora. “Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing.Pharmgenomics Pers Med 14 (2021): 877–86. https://doi.org/10.2147/PGPM.S314972.
Haga SB, Mills R, Moaddeb J, Liu Y, Voora D. Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing. Pharmgenomics Pers Med. 2021;14:877–86.
Haga, Susanne B., et al. “Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing.Pharmgenomics Pers Med, vol. 14, 2021, pp. 877–86. Pubmed, doi:10.2147/PGPM.S314972.
Haga SB, Mills R, Moaddeb J, Liu Y, Voora D. Independent Community Pharmacists' Experience in Offering Pharmacogenetic Testing. Pharmgenomics Pers Med. 2021;14:877–886.

Published In

Pharmgenomics Pers Med

DOI

ISSN

1178-7066

Publication Date

2021

Volume

14

Start / End Page

877 / 886

Location

New Zealand

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1103 Clinical Sciences